Oleate, not ligands of the receptor for advanced glycation end-products, promotes proliferation of human arterial smooth muscle cells

Diabetologia

Volumn 46, Issue 12, 2003, Pages 1676-1687

  Renard, C B ^a,b   Askari, B ^a   Suzuki, L A ^a   Kramer, F ^a   Bornfeldt, K E ^a,c  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b INSERM   (France)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Atherosclerosis; Diabetes; Diacylglycerol; Fatty acids; Phospholipase D; Platelet derived growth factor; Triglycerides

Indexed keywords

6 N CARBOXYMETHYLLYSINE; ADVANCED GLYCATION END PRODUCT; AMYLOID BETA PROTEIN; CHOLESTEROL ESTER; DIACYLGLYCEROL; FATTY ACID DERIVATIVE; LIGAND; METHYLGLYOXAL; OLEIC ACID; PHOSPHOLIPASE D; PHOSPHOLIPID; PLATELET DERIVED GROWTH FACTOR BB; PROTEIN S100B; RECEPTOR; TRIACYLGLYCEROL;

ARTERY MUSCLE; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CELL COUNT; CELL CYCLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; DNA SYNTHESIS; DYSLIPIDEMIA; ENZYME ACTIVITY; GAS CHROMATOGRAPHY; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPERGLYCEMIA; MITOGENESIS; PRIORITY JOURNAL; THIN LAYER CHROMATOGRAPHY;

AORTA; ARTERIOSCLEROSIS; CELL CYCLE; CELL DIVISION; CELLS, CULTURED; HUMANS; INFANT, NEWBORN; LIGANDS; MODELS, BIOLOGICAL; MUSCLE, SMOOTH, VASCULAR; OLEIC ACID; RECEPTORS, IMMUNOLOGIC;

EID: 0346216151     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-003-1247-9     Document Type: Article

References (66)

1. Donahue RP, Orchard TJ (1992) Diabetes mellitus and macrovascular complications. An epidemiological perspective. Diabetes Care 15:1141-1155
2. Suzuki L, Poot M, Gerrity RG, Bornfeldt KE (2001) Diabetes accelerates smooth muscle accumulation in lesions of atherosclerosis: lack of direct growth promoting effects of high glucose levels. Diabetes 50:851-860
3. Singh R, Barden A, Mori T, Beilin L (2001) Advanced glycation end-products: a review. Diabetologia 44:129-146
4. Kume S, Takeya M, Mori T, Araki N, Suzuki H, Horiuchi S, Kodama T, Miyauchi Y, Takahashi K (1995) Immunohistochemical and ultrastructural detection of advanced glycation end products in atherosclerotic lesions of human aorta with a novel specific monoclonal antibody. Am J Pathol 147:654-667
5. Vlassara H, Li YM, Imani F, Wojciechowicz D, Yang Z, Liu F, Cerami A (1995) Identification of galectin-3 as a high-affinity binding protein for advanced glycation end products (AGE): a new member of AGE-receptor complex. Mol Med 1:634-646
6. Li YM, Mitsuhashi T, Wojciechowicz D, Shimizu N, Li J, Stitt A, He C, Banerjee D, Vlassara H (1996) Molecular identity and cellular distribution of advanced glycation endproduct receptors: relationship of p60 to OST-48 and p90 to 80K-H membrane proteins. Proc Natl Acad Sci USA 93:11047-11052
7. Neeper M, Schmidt AM, Brett J, Yan SD, Wang F, Pan YC, Elliston K, Stern D, Shaw A (1992) Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem 267:14998-15004
8. Ohgami N, Nagai R, Ikemoto M, Arai H, Kuniyasu A, Horiuchi S, Nakayama H (2001) CD36, a member of the class b scavenger receptor family, as a receptor for advanced glycation end products. J Biol Chem 276:3195-3202
9. Araki N, Higashi T, Mori T, Shibayama R, Kawabe Y, Kodama T, Takahashi K, Shichiri M, Horiuchi S (1995) Macrophage scavenger receptor mediates the endocytic uptake and degradation of advanced glycation end products of the Maillard reaction. Eur J Biochem 230:408-415
10. Stem D, Yan SD, Yan SF, Schmidt AM (2002) Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings. Adv Drug Deliv Rev 54:1615-1625
11. Park L, Raman KG, Lee KJ, Lu Y, Ferran LJ Jr, Chow WS, Stern D, Schmidt AM (1998) Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts. Nat Med 4:1025-1031
12. Kislinger T, Tanji N, Wendt T, Qu W, Lu Y, Ferran LJ Jr, Taguchi A, Olson K, Bucciarelli L, Goova M, Hofmann MA, Cataldegirmen G, D'Agati V, Pischetsrieder M, Stern DM, Schmidt AM (2001) Receptor for advanced glycation end products mediates inflammation and enhanced expression of tissue factor in vasculature of diabetic apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol 21:905-910
13. Basta G, Lazzerini G, Massaro M, Simoncini T, Tanganelli P, Fu C, Kislinger T, Stern DM, Schmidt AM, De Caterina R (2002) Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: a mechanism for amplification of inflammatory responses. Circulation 105:816-822
14. Faergeman O (2000) Hypertriglyceridemia and the fibrate trials. Curr Opin Lipidol 11:609-614
15. Erkelens DW (1998) Diabetic dyslipidaemia. Eur Heart J 19 (Suppl H):H27-H40
16. Gerrity RG, Natarajan R, Nadler JL, Kimsey T (2001) Diabetes-induced accelerated atherosclerosis in swine. Diabetes 50:1654-1665
17. Dixon JL, Shen S, Vuchetich JP, Wysocka E, Sun GY, Sturek M (2002) Increased atherosclerosis in diabetic dyslipidemia swine: protection by atorvastatin involves decreased VLDL triglycerides but minimal effects on the lipoprotein profile. J Lipid Res 43:1618-1629
18. Pentikainen MO, Oksjoki R, Oorni K, Kovanen PT (2002) Lipoprotein lipase in the arterial wall: linking LDL to the arterial extracellular matrix and much more. Arterioscler Thromb Vasc Biol 22:211-217
19. Brynes AE, Edwards CM, Jadhav A, Ghatei MA, Bloom SR, Frost GS (2000) Diet-induced change in fatty acid composition of plasma triacylglycerols is not associated with change in glucagon-like peptide 1 or insulin sensitivity in people with type 2 diabetes. Am J Clin Nutr 72:1111-1118
20. Seigneur M, Freyburger G, Gin H, Claverie M, Lardeau D, Lacape G, Le Moigne F, Crockett R, Boisseau MR (1994) Serum fatty acid profiles in type I and type II diabetes: metabolic alterations of fatty acids of the main serum lipids. Diabet Res Clin Pract 23:169-177
21. Rybalkin SD, Bornfeldt KE, Sonnenburg WK, Rybalkina IG, Kwak KS, Hanson K, Krebs EG, Beavo JA (1997) Calmodulin-stimulated cyclic nucleotide phosphodiesterase (PDE1C) is induced in human arterial smooth muscle cells of the synthetic, proliferative phenotype. J Clin Invest 100:2611-2621
22. Hamad NM, Elconin JH, Karnoub AE, Bai W, Rich JN, Abraham RT, Der CJ, Counter CM (2002) Distinct requirements for Ras oncogenesis in human versus mouse cells. Genes Dev 16:2045-2057
23. Renard CB, Bornfeldt KE (2001) Human arterial smooth muscle cells rapidly deplete cell culture media of glucose. Diabetologia 44:1067-1068
24. Wautier JL, Paton C, Wautier MP, Pintigny D, Abadie E, Passa P, Caen JP (1981) Increased adhesion of erythrocytes to endothelial cells in diabetes mellitus and its relation to vascular complications. N Engl J Med 305:237
25. ε-(carboxymethyl) lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression. J Biol Chem 274:31740-31749
26. Westwood ME, Argirov OK, Abordo EA, Thornalley PJ (1997) Methylglyoxal-modified arginine residues - a signal for receptor-mediated endocytosis and degradation of proteins by monocytic THP-1 cells. Biochim Biophys Acta 1356:84-94
27. Habeeb A (1966) Determination of free amino groups in proteins by trinitrobenzenesulfonic acid. Anal Biochem 14:328-336
28. Hamilton JA, Kamp F (1999) How are free fatty acids transported in membranes? Is it by proteins or by free diffusion through the lipids? Diabetes 48:2255-2269
29. Smith EB, Staples EM (1980) Distribution of plasma proteins across the human aortic wall-barrier functions of endothelium and internal elastic lamina. Atherosclerosis 37:579-590
30. Rabinovitch PS (1994) DNA content histogram and cell-cycle analysis. Methods Cell Biol 41:263-296
31. Zapolska-Downar D, Zapolski-Downar A, Markiewski M, Ciechanowicz A, Kaczmarczyk M, Naruszewicz M (2000) Selective inhibition by α-tocopherol of vascular cell adhesion molecule-1 expression in human vascular endothelial cells. Biochem Biophys Res Commun 274:609-615
32. Bligh E, Dyer W (1959) A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37:911-917
33. Lepage G, Roy CC (1986) Direct transesterification of all lipids in a one step reaction. J Lipid Res 27:114-120
34. Satia JA, Patterson RE, Herrero R, Jin F, Dai Q, King IB, Chen C, Kristal AR, Prentice RL, Rossing MA (1999) Study of diet, biomarkers and cancer risk in the United States, China and Costa Rica. Int J Cancer 82:28-32
35. Thornalley PJ (2002) Glycation in diabetic neuropathy: characteristics, consequences, causes, and therapeutic options. Int Rev Neurobiol 50:37-57
36. Degenhardt TP, Thorpe SR, Baynes JW (1998) Chemical modification of proteins by methylglyoxal. Cell Mol Biol 44:1139-1145
37. Thornalley PJ, Battah S, Ahmed N, Karachalias N, Agalou S, Babaei-Jadidi R, Dawnay A (2003) Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry. Biochem J 375:581-592
38. Reddy S, Bichler J, Wells-Knecht K, Thorpe S, Baynes J (1995) Carboxymethyllysine is a dominant AGE antigen in tissue proteins. Biochemistry 34:10872-10878
39. Mizutani K, Ikeda K, Yamori Y (2000) Resveratrol inhibits AGEs-induced proliferation and collagen synthesis activity in vascular smooth muscle cells from stroke-prone spontaneously hypertensive rats. Biochem Biophys Res Commun 274:61-67
40. Wang R, Kudo M, Yokoyama M, Asano G (2001) Roles of advanced glycation endproducts (AGE) and receptor for AGE on vascular smooth muscle cell growth. J Nippon Med Sch 68:472-481
41. Satoh H, Togo M, Hara M, Miyata T, Han K, Maekawa H, Ohno M, Hashimoto Y, Kurokawa K, Watanabe T (1997) Advanced glycation endproducts stimulate mitogen-activated protein kinase and proliferation in rabbit vascular smooth muscle cells. Biochem Biophys Res Commun 239:111-115
42. Sakata N, Meng J, Takebayashi S (2000) Effects of advanced glycation end products on the proliferation and fibronectin production of smooth muscle cells. J Atheroscler Thromb 7:169-176
43. Higashi T, Sano H, Saishoji T, Ikeda K, Jinnouchi Y, Kanzaki T, Morisaki N, Rauvala H, Shichiri M, Horiuchi S (1997) The receptor for advanced glycation end products mediates the chemotaxis of rabbit smooth muscle cells. Diabetes 46:463-472
44. Iino K, Yoshinari M, Yamamoto M, Kaku K, Doi Y, Ichikawa K, Iwase M, Fujishima M (1996) Effect of glycated collagen on proliferation of human smooth muscle cells in vitro. Diabetologia 39:800-806
45. Sakaguchi T, Yan SF, Yan SD, Belov D, Rong LL, Sousa M, Andrassy M, Marso SP, Duda S, Arnold B, Liliensiek B, Nawroth PP, Stern DM, Schmidt AM, Naka Y (2003) Central role of RAGE-dependent neointimal expansion in arterial restenosis. J Clin Invest 111:959-972
46. Wautier MP, Chappey O, Corda S, Stern DM, Schmidt AM, Wautier JL (2001) Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. Am J Physiol Endocrinol Metab 280:E685-E694
47. Sengoelge G, Fodinger M, Skoupy S, Ferrara I, Zangerle C, Rogy M, Horl WH, Sunder-Plassmann G, Menzel J (1998) Endothelial cell adhesion molecule and PMNL response to inflammatory stimuli and AGE-modified fibronectin. Kidney Int 54:1637-1651
48. Kirstein M, Brett J, Radoff S, Ogawa S, Stern D, Vlassara H (1990) Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging. Proc Natl Acad Sci USA 87:9010-9014
49. Miyata T, Inagi R, Iida Y, Sato M, Yamada N, Oda O, Maeda K, Seo H (1994) Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleukin-1. J Clin Invest 93:521-528
50. Lu G, Meier KE, Jaffa AA, Rosenzweig SA, Egan BM (1998) Oleic acid and angiotensin II induce synergistic mitogenic response in vascular smooth muscle cells. Hypertension 31:978-985
51. Kwok CF, Shih KC, Hwu CM, Ho LT (2000) Linoleic acid and oleic acid increase the endothelin-1 binding and action in cultured rat aortic smooth muscle cells. Metabolism 49:1386-1389
52. Askari B, Carroll MA, Capparelli M, Kramer F, Gerrity RG, Bornfeldt KE (2002) Oleate and linoleate enhance the growth-promoting effects of insulin-like growth factor-I through a phospholipase D-dependent pathway in arterial smooth muscle cells. J Biol Chem 277:36338-36344
53. Lu X, Yang XY, Howard RL, Walsh JP (2000) Fatty acids modulate protein kinase C activation in porcine vascular smooth muscle cells independently of their effect on de novo diacylglycerol synthesis. Diabetologia 43:1136-1144
54. Inui H, Kitami Y, Tani M, Kondo T, Inagami T (1994) Differences in signal transduction between platelet-derived growth factor (PDGF) alpha and beta receptors in vascular smooth muscle cells. PDGF-BB is a potent mitogen, but PDGF-AA promotes only protein synthesis without activation of DNA synthesis. J Biol Chem 269:30546-30552
55. Shome K, Rizzo MA, Vasudevan C, Andresen B, Romero G (2000) The activation of phospholipase D by endothelin-1, angiotensin II, and platelet-derived growth factor in vascular smooth muscle A10 cells is mediated by small G proteins of the ADP-ribosylation factor family. Endocrinology 141:2200-2208
56. Bornfeldt KE, Raines EW, Nakano T, Graves LM, Krebs EG, Ross R (1994) Insulin-like growth factor-I and platelet-derived growth factor-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are distinct from those of proliferation. J Clin Invest 93:1266-1274
57. Du X, Jiang Y, Qian W, Lu X, Walsh JP (2001) Fatty acids inhibit growth-factor-induced diacylglycerol kinase α activation in vascular smooth-muscle cells. Biochem J 357:275-282
58. Sánchez-Pinera P, Micol V, Corbalan-Garcia S, Gomez-Fernandez JC (1999) A comparative study of the activation of protein kinase Cα by different diacylglycerol isomers. Biochem J 337:387-395
59. Yu HY, Inoguchi T, Kakimoto M, Nakashima N, Imamura M, Hashimoto T, Umeda F, Nawata H (2001) Saturated non-esterified fatty acids stimulate de novo diacylglycerol synthesis and protein kinase c activity in cultured aortic smooth muscle cells. Diabetologia 44:614-620
60. Singer P, Gnauck G, Honigmann G, Schliack V, Laeuter J (1977) The fatty acid composition of triglycerides in arteries, depot fat and serum of amputated diabetics. Atherosclerosis 28:87-92
61. Bohov P, Baláz V, Seböková E, Klimes I (1997) The effect of hyperlipidemia on serum fatty acid composition in type 2 diabetics. Ann NY Acad Sci 827:561-567
62. Kelley DE, Simoneau JA (1994) Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus. J Clin Invest 94:2349-2356
63. Schwertner HA, Mosser EL (1993) Comparison of lipid fatty acids on a concentration basis vs weight percentage basis in patients with and without coronary artery disease or diabetes. Clin Chem 39:659-663
64. Lecomte M, Claire M, Deneuville M, Wiernsperger N (1998) Fatty acid composition of phospholipids and neutral lipids from human diabetic small arteries and veins by a new TLC method. Prostaglandins Leukot Essent Fatty Acids 59:363-369
65. Sartippour MR, Lambert A, Laframboise M, St-Jacques P, Renier G (1998) Stimulatory effect of glucose on macrophage lipoprotein lipase expression and production. Diabetes 47:431-438
66. Babaev VR, Patel MB, Semenkovich CF, Fazio S, Linton MF (2000) Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in low density lipoprotein receptor-deficient mice. J Biol Chem 275:26293-26299